ARWR
Price
$19.90
Change
-$1.06 (-5.06%)
Updated
Feb 21 closing price
Capitalization
2.51B
74 days until earnings call
LXEO
Price
$3.89
Change
-$0.14 (-3.47%)
Updated
Feb 21 closing price
Capitalization
128.67M
22 days until earnings call
Ad is loading...

ARWR vs LXEO

Header iconARWR vs LXEO Comparison
Open Charts ARWR vs LXEOBanner chart's image
Arrowhead Pharmaceuticals
Price$19.90
Change-$1.06 (-5.06%)
Volume$1.2M
Capitalization2.51B
Lexeo Therapeutics
Price$3.89
Change-$0.14 (-3.47%)
Volume$179.26K
Capitalization128.67M
ARWR vs LXEO Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARWR vs. LXEO commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a Hold and LXEO is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ARWR: $19.90 vs. LXEO: $3.89)
Brand notoriety: ARWR: Notable vs. LXEO: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 60% vs. LXEO: 74%
Market capitalization -- ARWR: $2.51B vs. LXEO: $128.67M
ARWR [@Biotechnology] is valued at $2.51B. LXEO’s [@Biotechnology] market capitalization is $128.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, ARWR is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 4 TA indicator(s) are bullish while LXEO’s TA Score has 4 bullish TA indicator(s).

  • ARWR’s TA Score: 4 bullish, 4 bearish.
  • LXEO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ARWR and LXEO are a good buy in the short-term.

Price Growth

ARWR (@Biotechnology) experienced а -0.25% price change this week, while LXEO (@Biotechnology) price change was -13.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ARWR is expected to report earnings on May 08, 2025.

LXEO is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.51B) has a higher market cap than LXEO($129M). ARWR YTD gains are higher at: 5.851 vs. LXEO (-40.881). LXEO has higher annual earnings (EBITDA): -84.47M vs. ARWR (-561.51M). ARWR has more cash in the bank: 681M vs. LXEO (157M). LXEO has less debt than ARWR: LXEO (10.4M) vs ARWR (511M). ARWR has higher revenues than LXEO: ARWR (3.55M) vs LXEO (0).
ARWRLXEOARWR / LXEO
Capitalization2.51B129M1,945%
EBITDA-561.51M-84.47M665%
Gain YTD5.851-40.881-14%
P/E RatioN/AN/A-
Revenue3.55M0-
Total Cash681M157M434%
Total Debt511M10.4M4,913%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRLXEO
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LXEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMMPX22.32-0.02
-0.09%
Morgan Stanley Inst Emerging Mkts R6
IBNCX23.54-0.23
-0.97%
Macquarie Balanced Fund Class C
MKSCX12.31-0.17
-1.36%
BlackRock Sustainable Advantage Gbl Eq K
STSOX31.81-0.82
-2.51%
Sterling Capital SmCp Val C
JANIX26.82-0.70
-2.54%
Janus Henderson Triton D

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-5.06%
NTLA - ARWR
49%
Loosely correlated
-0.65%
CRNX - ARWR
47%
Loosely correlated
+1.63%
ALNY - ARWR
46%
Loosely correlated
-0.16%
AXON - ARWR
46%
Loosely correlated
-5.28%
FATE - ARWR
46%
Loosely correlated
-8.09%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with RCKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-3.47%
RCKT - LXEO
39%
Loosely correlated
-3.68%
ARWR - LXEO
38%
Loosely correlated
-5.06%
PRME - LXEO
37%
Loosely correlated
-5.27%
CABA - LXEO
34%
Loosely correlated
-1.44%
IONS - LXEO
32%
Poorly correlated
-1.13%
More